# Raw Agent Run Log

- `run_id`: RUN_20260529_113557_05_openclaw_deepseekv4pro_isolated
- `case_id`: C008
- `variant_id`: level1
- `level`: level1
- `agent_name`: openclaw
- `agent_id`: benchmark_isolated
- `model`: deepseek-v4-pro
- `model_provider`: deepseek
- `openclaw_build_or_version`: 2026.5.5
- `channel`: cli
- `temperature`: not_supported
- `top_p`: not_supported
- `max_tokens`: not_supported
- `seed`: not_supported
- `tools_enabled`: locally_isolated_remote_tool_enabled
- `closed_book`: false
- `timestamp`: 2026-05-29T11:35:57+0800
- `input_file`: benchmark/cases/C008_retail_tax_salience/agent_task_level1.md
- `system_prompt_summary`: workspace=/Users/jiangcanxiang/OpenClawBenchmarkIsolated; thinking=high; actual_tool_use=none; agent=benchmark_isolated
- `contamination_status`: unknown
- `contamination_reason`: pending manual content review; actual tool use=none
- `status`: success

## Raw Agent Output

# Research Design: Causal Effect of Visible All-In Pricing on Consumer Demand

---

## 1. Executive Summary

This research design addresses whether making a previously hidden add-on charge visible at the point of product choice changes consumer purchasing behavior. The core challenge is separating the causal effect of price salience from confounding forces: secular demand trends, store-level shocks, category-specific shifts, and concurrent marketing activities (promotions, discounts, stock changes). I propose a **difference-in-differences (DiD) design** with treated and untreated products observed over time, supplemented by event-study specifications to test for parallel pre-trends and dynamic treatment effects. Where the data structure permits, a **triple-differences (DDD)** extension using untreated stores or product categories adds robustness. The design can yield credible short-run causal estimates of salience effects on demand, conditional on parallel trends holding and on adequate controls for concurrent price and promotion changes.

---

## 2. Research Question

What is the causal effect of making an add-on charge visible at the point of product choice (on the shelf or display) on consumer quantity demanded, holding the underlying economic price constant?

---

## 3. Target Estimand

The **average treatment effect on the treated (ATT)** for product-level quantity demanded:

> **ATT** = E[Y(1) — Y(0) | Treatment = 1, Post = 1]

where *Y(1)* is demand under visible all-in pricing, *Y(0)* is demand under the status-quo display (hidden add-on charge), and the conditioning set includes products actually exposed to the display change during the post-intervention period.

If the ATT is not credibly identified, the strongest defensible estimand is the **conditional difference-in-differences** association between the display intervention and quantity demanded, after controlling for observable price, promotion, and product characteristics — interpreted as a well-controlled descriptive estimate rather than a causal claim.

---

## 4. Treatment / Exposure and Main Outcomes

| Element | Definition |
|---|---|
| **Treatment** | A product's shelf/display label is changed to show the all-in price (shelf price plus the previously hidden add-on charge) alongside the shelf price, or replacing the shelf-price-only display. Treatment occurs at the product level within treated stores. |
| **Main outcome** | Quantity sold per product per store per time period (e.g., weekly units). Alternative specifications could use log quantity, revenue, or category share. |
| **Exposure intensity** (optional) | If the add-on charge varies across products (e.g., a percentage rate applied to different base prices), the treatment "dose" — the gap between shelf price and all-in price — varies, enabling a continuous-treatment or dose-response analysis. |

---

## 5. Data Structure Summary

The researcher observes a **product × store × time panel**:

- **Cross-section**: Products (SKUs) nested within product categories, sold across multiple stores.
- **Time**: Regular periods (e.g., weeks) covering pre-intervention and post-intervention windows.
- **Treatment indicator**: A binary variable marking which products (in which stores) receive the display change, and from which date.
- **Comparison units**: Untreated products within the same stores, untreated stores carrying the same products, or both.
- **Covariates**: Unit price (shelf price, all-in price), any promotional flags, product category, store identifier, and time period.

---

## 6. Relevant Causal Mechanisms

1. **Attention / salience channel**: Consumers underestimate or ignore the add-on charge when it is hidden. Making it visible at the shelf draws attention to the true cost, reducing demand for treated products (if the add-on charge is positive) as consumers perceive a higher price and may substitute away.

2. **Time-shock channel**: Aggregate demand for the category, store traffic, or economic conditions change over the study window for reasons unrelated to the intervention. A simple before-after comparison would confound these with the treatment effect.

3. **Category-composition channel**: Treated product categories may have different demand trends, seasonality, or price elasticities than untreated categories. Without proper controls, pre-existing category differences are mistaken for treatment effects.

4. **Measurement / confound channel**: Observed demand changes may reflect concurrent price changes, promotions, stockouts, or assortment changes rather than salience. The design must isolate salience from these confounds.

5. **Substitution / spillover channel**: If consumers substitute from treated products to untreated products (within or across categories), the untreated group is contaminated, biasing the DiD estimate. This is a threat to the stable unit treatment value assumption (SUTVA).

---

## 7. Main Identification Challenge

The core challenge is **non-random treatment assignment correlated with potential outcomes**. Products selected for the display change may differ systematically from unselected products in ways that independently predict demand trends:

- Retailers may choose high-margin, high-visibility, or strategically important categories for the intervention.
- The timing may coincide with category resets, seasonal transitions, or other merchandising changes.
- Treated products may be in categories with different intrinsic demand trajectories.

Without random assignment, the counterfactual — what would have happened to treated products absent the intervention — must be constructed from comparison units whose pre-intervention trends are credibly parallel.

---

## 8. Is Credible Causal Identification Possible?

**Yes, in principle**, if:

- The researcher can identify a set of untreated products (or product × store combinations) whose pre-intervention demand trends closely parallel those of treated units.
- The data contain a sufficient pre-intervention window to test and visually confirm parallel trends.
- Concurrent price changes, promotions, and stock conditions are observable and can be controlled for.
- Spillover effects between treated and untreated products are limited, or the comparison group is chosen to minimize contamination.

If these conditions are not met — particularly if parallel pre-trends fail or if the treatment is confounded with unobserved shocks — then **causal identification is not credible**, and the analysis should be presented as a descriptive conditional association with transparent caveats.

---

## 9. Proposed Empirical Design

### Primary Design: Difference-in-Differences (DiD)

Compare the change in demand for treated products (before vs. after the display change) to the change in demand for untreated products over the same period.

**Treatment group**: Products (in specific stores) that receive the all-in price display.
**Control group**: Products in the same stores and categories that do not receive the display change; or the same products in untreated stores.

The DiD estimator subtracts the pre-post change in the control group from the pre-post change in the treatment group, removing common time trends shared by both groups.

### Extended Design: Event Study

Generalize the DiD to estimate dynamic treatment effects period-by-period around the intervention date:

- Estimate separate coefficients for each period relative to treatment (e.g., t = −12, …, −1, 0, +1, …, +12 weeks).
- The pre-treatment coefficients serve as a direct test of parallel trends: they should be statistically indistinguishable from zero.
- Post-treatment coefficients reveal the time path of the treatment effect (immediate, delayed, persistent, decaying).

### Supplementary Design: Triple Differences (DDD)

If data include both treated and untreated stores, a DDD design adds a third difference:

- **Difference 1**: Treated products vs. untreated products (within store).
- **Difference 2**: Treated stores vs. untreated stores.
- **Difference 3**: Pre vs. post intervention.

The DDD estimator nets out both product-specific and store-specific shocks, providing additional robustness when the parallel trends assumption is questionable at the product-within-store level.

---

## 10. Why the Design Is Valid (or Why Not)

**Validity argument for DiD**:

- The parallel trends assumption is testable with pre-intervention data. If treated and untreated units show statistically indistinguishable trends in the pre-period, the counterfactual constructed from the control group is credible.
- The design differences out time-invariant unobserved heterogeneity across products (product fixed effects) and common time shocks (time fixed effects).
- The event-study specification reveals whether effects emerge precisely at the intervention date (supporting a causal interpretation) or pre-date it (suggesting confounding).

**Caveats**:

- Parallel pre-trends do not guarantee parallel counterfactual trends post-intervention; this remains an untestable assumption.
- If treatment assignment is correlated with time-varying unobservables (e.g., a product-specific demand shock coinciding with the intervention), the DiD estimate is biased.
- SUTVA violations (spillover) can bias the control group.

---

## 11. Required Assumptions

| Assumption | Description | Testable? |
|---|---|---|
| **Parallel trends** | In the absence of treatment, treated and untreated units would have followed parallel demand trajectories. | Partially: testable in the pre-period via event-study coefficients and visual inspection. |
| **No anticipation** | Consumers and retailers did not change behavior before the intervention in anticipation of it. | Testable: pre-period event-study coefficients near t = 0 should not diverge. |
| **SUTVA / no spillover** | The treatment of one product does not affect demand for untreated products (or the contamination is small). | Partially testable: examine demand patterns in products adjacent to treated ones; use stores or categories distant from treatment as alternative controls. |
| **No simultaneous confounding shocks** | No other policy change, promotion cycle, or supply disruption coincided exactly with the display change for treated but not untreated units. | Not directly testable; requires institutional knowledge and robustness checks. |
| **Correct specification of functional form** | The additive separability of unit and time effects in the DiD model is appropriate. | Assess via residual diagnostics and alternative specifications (e.g., Poisson for count outcomes). |
| **Stable composition** | The set of products in treated and control groups does not change systematically (no entry/exit correlated with treatment). | Testable: check product churn rates in treated vs. untreated groups around the intervention. |

---

## 12. Statistical Model / Analysis Equation

### Baseline Two-Way Fixed Effects (TWFE) DiD

```
Q_{ist} = α + β · (Treat_i × Post_t) + γ_i + λ_t + X_{ist}δ + ε_{ist}
```

Where:
- *Q_{ist}* = quantity sold of product *i* in store *s* in week *t* (or log quantity)
- *Treat_i* = 1 if product *i* is ever treated, 0 otherwise
- *Post_t* = 1 for weeks after the display change, 0 before
- *β* = the DiD coefficient of interest (ATT under parallel trends)
- *γ_i* = product fixed effects (or product × store fixed effects)
- *λ_t* = time (week) fixed effects
- *X_{ist}* = vector of time-varying controls (shelf price, promotion dummy, stockout indicator)
- Standard errors clustered at the product level (or product × store level)

### Event-Study Specification

```
Q_{ist} = α + Σ_{k ≠ −1} β_k · D_{it}^k + γ_i + λ_t + X_{ist}δ + ε_{ist}
```

Where *D_{it}^k* indicators equal 1 when product *i* is *k* periods from treatment in week *t*, with *k* = −1 (the period just before treatment) as the omitted reference category.

### Triple Differences (DDD) Extension

```
Q_{icst} = β · (Treat_c × Post_t × StoreTreat_s) + γ_{ic} + γ_{is} + γ_{ct} + γ_{st} + X_{icst}δ + ε_{icst}
```

Where *StoreTreat_s* = 1 for stores where the display change is implemented (for targeted products), and the fixed effects absorb product × category, product × store, category × time, and store × time variation.

### Dose-Response Specification (if charge rate varies)

```
Q_{ist} = α + β · (Post_t × Dose_i) + γ_i + λ_t + X_{ist}δ + ε_{ist}
```

Where *Dose_i* is the magnitude of the add-on charge for product *i* (e.g., the absolute or percentage gap between shelf price and all-in price). A negative *β* would indicate stronger demand reduction for products with larger previously hidden charges.

---

## 13. Robustness, Placebo, and Falsification Checks

### Placebo Tests

1. **In-time placebo**: Estimate the DiD model using a fake intervention date before the actual intervention (e.g., 6 or 12 months earlier). A null result supports the assumption that no differential pre-trends drive the main result.

2. **In-group placebo**: Apply the treatment label to products that were never treated but are observationally similar to treated products. A null result suggests the main effect is not driven by group composition.

3. **In-outcome placebo**: Estimate the model on an outcome that should not be affected by the display change (e.g., demand for a distant, unrelated product category). A null result supports that the design is not picking up spurious correlations.

### Robustness Checks

1. **Alternative control groups**: Re-estimate using different comparison sets — untreated products within the same narrow category, untreated products in untreated stores, products matched on pre-treatment demand trends via synthetic control or propensity score matching.

2. **Alternative functional forms**: Log-linear, Poisson pseudo-maximum likelihood (PPML), or inverse hyperbolic sine transformations to address zeros and heteroskedasticity.

3. **Leave-one-out**: Drop one treated product or one store at a time to confirm the result is not driven by outliers.

4. **Varying time windows**: Estimate using symmetric windows (±3, ±6, ±12 months) around the intervention to check sensitivity to window choice.

5. **Donut RD / bandwidth sensitivity**: If the intervention has a sharp onset date, estimate using only data near the cutoff to reduce the influence of distant time periods.

### Event-Study Diagnostics

- Plot event-study coefficients with 95% confidence intervals.
- Test the joint null that all pre-treatment coefficients equal zero (F-test).
- Test for a level shift at treatment (β₀) vs. a trend break.

---

## 14. Heterogeneity Analysis

If data support the following dimensions, heterogeneity analysis can illuminate mechanisms and external validity:

1. **By product category**: Are salience effects larger for categories with higher add-on charge rates, lower baseline price transparency, or more substitutable alternatives?

2. **By charge magnitude (dose-response)**: Do products with larger absolute or percentage add-on charges exhibit larger demand responses? This directly tests the attention mechanism.

3. **By store characteristics**: Do effects differ by store type (e.g., urban vs. rural, high vs. low income area), reflecting different consumer price sensitivity or attention?

4. **By product price level**: Are effects larger for low-price products (where the add-on charge may be a larger share) or high-price products (where the absolute charge is larger)? This helps distinguish proportional vs. absolute attention effects.

5. **By time since intervention**: Do effects persist, decay, or grow? The event-study specification directly estimates this.

**Important caveat**: Heterogeneity analyses are correlational, not causal, unless the dimensions of heterogeneity are themselves randomly assigned or instrumented.

---

## 15. Measurement, Compliance, Missingness, Spillover, and Implementation Limits

| Concern | Mitigation |
|---|---|
| **Measurement error in the treatment date** | If the rollout was staggered across stores/products, model it with staggered adoption DiD estimators (e.g., Callaway-Sant'Anna, Sun-Abraham) to avoid biases from heterogeneous treatment effects with differential timing. |
| **Compliance / partial treatment** | Some products may have had the display change implemented inconsistently (e.g., shelf labels not updated promptly). If implementation fidelity data exist, estimate intention-to-treat (ITT) and, if instrumentable, local average treatment effects (LATE). |
| **Missing outcomes** | Zero-sales periods may indicate stockouts, delisting, or genuine zero demand. Distinguish these cases where possible; use PPML or two-part models if zeros are structural. |
| **Spillover / SUTVA** | Test whether untreated products in the same category (or adjacent shelf space) as treated products show demand changes after the intervention. If spillover is detected, restrict the control group to products in untreated stores or distant categories. |
| **Product entry/exit** | Products entering or exiting during the study window create an unbalanced panel. Restrict to a balanced panel of continuously available products for the main analysis; conduct sensitivity analysis including all products. |
| **Promotion and price changes** | Control for observable promotions and prices. To the extent that promotions are unobservable or endogenous, the salience effect cannot be fully separated from correlated merchandising changes. |

---

## 16. Failure Modes and Alternative Explanations

| Failure Mode | Description | Diagnostic |
|---|---|---|
| **Confounded timing** | The display change coincided with a price change, promotion, category reset, or seasonal shift that differentially affected treated products. | Check for discrete changes in controlled covariates at the intervention date. Conduct in-time placebo tests. |
| **Non-parallel trends** | Treated and untreated products were on different demand trajectories before the intervention. | Visual and statistical pre-trend tests. If parallel trends fail, the DiD is not valid; consider synthetic control or matching to construct a better counterfactual. |
| **Anticipation effects** | Consumers learned about the display change before implementation and shifted purchases forward or backward. | Test for demand changes in the periods immediately preceding the intervention. |
| **Spillover contamination** | Demand shifted from treated to untreated products, inflating the control group's post-period demand and exaggerating the DiD estimate. | Test for control-group demand increases post-intervention; use untreated-store controls. |
| **Hawthorne / observer effects** | The act of measuring or implementing the display change altered store operations or consumer experience beyond the price display itself. | Compare treated stores to untreated stores (if available) to absorb store-level implementation effects. |
| **Compositional change** | The mix of consumers shopping at treated stores changed post-intervention (e.g., price-sensitive consumers switched stores). | Test for changes in total store traffic or customer demographics if available. |
| **Mean reversion** | Products were selected for treatment because they had unusually high or low recent demand; regression to the mean is mistaken for a treatment effect. | Examine pre-treatment demand trajectories for Ashenfelter's dip patterns. Use matching on pre-treatment demand levels. |

---

## 17. What Cannot Be Claimed

1. **Long-run equilibrium effects**: The design estimates short-run demand responses (weeks to months). It cannot speak to long-run adjustments in consumer search behavior, retailer pricing strategy, or competitive responses without a much longer panel.

2. **Welfare effects**: The design estimates quantity responses, not consumer surplus, deadweight loss, or distributional impacts. A demand reduction could reflect welfare-improving transparency or welfare-reducing "tax salience" — the design cannot distinguish these without a structural model of consumer utility.

3. **Mechanism decomposition**: The design cannot fully separate the "attention" mechanism from "annoyance" or "trust" mechanisms (consumers may reduce purchases not because they update price beliefs, but because they feel misled by the previous hidden charge).

4. **Generalizability to other settings**: Results from one retailer, one set of product categories, and one type of add-on charge do not necessarily generalize to different retail formats, charge types, or consumer populations.

5. **Causal claims about heterogeneity**: Subgroup differences are descriptive associations; they are not causally identified unless the subgroups are randomly assigned.

6. **Persistence beyond the observation window**: If the post-intervention window is short, claims about whether effects persist, decay, or reverse cannot be made.

---

## 18. Additional Data Needed

To strengthen the design, the following data would be valuable (but their absence does not necessarily invalidate the core approach):

1. **Implementation fidelity data**: Dates when each product's shelf label was actually updated, and whether the update was complete and accurate.
2. **Store traffic or customer count**: To distinguish per-customer quantity changes from changes in the number of shoppers.
3. **Consumer-level panel data** (e.g., loyalty card): To track within-consumer substitution patterns and test for heterogeneous attention by consumer type.
4. **Inventory and stockout data**: To distinguish demand-driven quantity changes from supply-side constraints.
5. **Competitor pricing**: If the add-on charge also applies at competitor stores but display practices differ, competitor data would provide an additional control.
6. **Pre-intervention consumer survey or attention measures**: To establish baseline awareness of the add-on charge and measure whether the display change actually increased salience (a manipulation check).
7. **Longer post-intervention panel**: To assess persistence, habit formation, or equilibrium adjustment.

---

## 19. Threat-Response Table

The task packet does not explicitly request a threat-response table as a separate numbered section, but the failure modes and diagnostics in Section 16 serve this purpose. A condensed version follows:

| Threat to Validity | Response / Diagnostic |
|---|---|
| Non-parallel pre-trends | Event-study pre-trend test; synthetic control if trends diverge |
| Simultaneous price/promotion changes | Control for observable prices and promotions; in-time placebo |
| Anticipation effects | Test pre-period coefficients near t = 0 for divergence |
| Spillover between treated and untreated | Comparison with untreated-store control group |
| Staggered rollout bias | Use modern staggered DiD estimators (Callaway-Sant'Anna, Sun-Abraham) |
| Product entry/exit | Balanced-panel restriction; sensitivity with full panel |
| Mean reversion / Ashenfelter's dip | Examine pre-treatment demand levels; match on pre-treatment outcomes |
| Functional form sensitivity | Log-linear, PPML, and IHS alternatives |

---

## 20. Claim-Evidence Table

| Claim | Evidence Used | Claim Type | Confidence | What Would Falsify This Claim |
|---|---|---|---|---|
| Visible all-in pricing reduces demand for treated products in the short run | DiD estimate of β < 0; event-study showing level drop at intervention date | **Causal** (conditional on parallel trends) | **High** (if pre-trends are parallel and confounds are controlled) | Null or positive DiD estimate; pre-trend divergence; effect appears before intervention |
| The effect operates through price salience rather than actual price changes | Control for shelf price and promotions; null result on price-change variable; stable prices around intervention | **Mechanism** (mediating) | **Moderate** | Observed demand change is fully explained by concurrent price changes when controlled |
| Effects are larger for products with larger hidden charges | Negative coefficient on Post × Dose interaction | **Descriptive association** | **Moderate** | Null interaction; the pattern could reflect other product characteristics correlated with charge magnitude |
| Effects differ by product category | Significant interaction between treatment and category indicators | **Descriptive association** | **Low–Moderate** | Null interactions; category differences may be confounded by category-level shocks |
| The control group provides a valid counterfactual | Pre-treatment event-study coefficients ≈ 0 (joint F-test not rejected); visual parallelism | **Diagnostic / assumption support** | **Moderate** (testable in pre-period only) | Significant pre-trend coefficients; visual divergence in pre-period |
| No meaningful spillover to untreated products | Null DiD estimate when using untreated products in untreated stores vs. untreated products in treated stores | **Diagnostic** | **Moderate** | Significant demand increase for untreated products in treated stores post-intervention |
| Results are not driven by a single product or store | Leave-one-out estimates remain stable and significant | **Robustness** | **High** | Point estimate changes substantially or loses significance when key units are excluded |
| The effect persists beyond the immediate intervention week | Event-study coefficients for k ≥ 1 remain negative and significant | **Descriptive dynamic pattern** | **Moderate** (window-dependent) | Coefficients revert to zero within the observation window; wide confidence intervals at longer horizons |

---

### Summary of Design Logic

The design's credibility rests on a chain of testable and untestable links:

1. **Testable**: Do treated and untreated products share parallel pre-trends? → Event-study pre-coefficients.
2. **Testable**: Does the demand shift coincide with the intervention date? → Event-study post-coefficients showing a discrete change at t = 0.
3. **Untestable**: Would parallel trends have continued absent the intervention? → This must be argued, not proven; institutional knowledge about why treatment timing was chosen is critical.
4. **Partially testable**: Are confounding shocks absent? → Placebo tests and covariate balance checks provide suggestive evidence but cannot rule out unobserved confounds.

When these links hold, the DiD design provides credible causal evidence on the short-run demand response to visible all-in pricing. When they fail, the strongest defensible analysis is a well-controlled descriptive comparison with transparent caveats about endogeneity.

## Tool Log Summary

- actual tool use: none
- trajectory `toolMetas`: []
- toolCall count: 0
- toolResult count: 0
- session_id: isolated_20260529_113557_52386_5
- session_log: /Users/jiangcanxiang/.openclaw/agents/benchmark_isolated/sessions/isolated_20260529_113557_52386_5.jsonl
- trajectory_log: /Users/jiangcanxiang/.openclaw/agents/benchmark_isolated/sessions/isolated_20260529_113557_52386_5.trajectory.jsonl

## Operator Notes

- duration_ms: 116678
- stderr_excerpt: [plugins] plugins.allow is empty; discovered non-bundled plugins may auto-load: qqbot (/Users/jiangcanxiang/.openclaw/npm/node_modules/@openclaw/qqbot/dist/index.js), openclaw-weixin (/Users/jiangcanxiang/.openclaw/npm/node_modules/@tencent-weixin/openclaw-weixin/dist/index.js). Set plugins.allow to explicit trusted ids. [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed root=~/.openclaw/skills reason=symlink-escape requested=~/.openclaw/skills/0-autoresearch-skill resolved=~/.orchestra/skills/0-autoresearch-skill [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed root=~/.openclaw/skills reason=symlink-escape requested=~/.openclaw/skills/brainstorming-research-ideas resolved=~/.orchestra/skills/21-research-ideation/brainstorming-research-ideas [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed root=~/.openclaw/skills reason=symlink-escape requested=~/.openclaw/skills/creative-thinking-for-research resolved=~/.orchestra/skills/21-research-ideation/creative-thinking-for-research [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed r
